Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy

American Journal of Surgery

Volumn 194, Issue 4, 2007, Pages 527-531

  Vo, Thao ^a   Xing, Yan ^a   Meric Bernstam, Funda ^a   Mirza, Nadeem ^a   Vlastos, Georges ^a   Symmans, W Fraser ^a   Perkins, George H ^a   Buchholz, Thomas A ^a   Babiera, Gildy V ^a   Kuerer, Henry M ^a   Bedrosian, Isabelle ^a   Akins, Jeri S ^a   Hunt, Kelly K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Breast conservation therapy; Invasive ductal carcinoma; Lumpectomy; Medullary carcinoma; Mucinous carcinoma; Tubular carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST DUCT; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DATA BASE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; INVASIVE DUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; MUCINOUS CARCINOMA; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548387846     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.06.012     Document Type: Article

References (9)

1. National Institutes of Health. Treatment of early-stage breast cancer. JAMA 265 (1991) 391-395
2. Gallager S.H. Pathologic types of breast cancer: their prognosis. Cancer 53 (1984) 623-629
3. Mansour E.G., Gray R., Shatila A.H., et al. Case: survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis. J Clin Oncol 16 (1998) 3486-3492
4. National Institutes of Health. Adjuvant therapy for breast cancer. National Institutes of Health Consensus Development Conference Statement, November 1-3, 2000.
5. Green F.L., Page D.L., Fleming I.D., et al. Breast. In: Green F.L., Page D.L., and Fleming I.D. (Eds). American Joint Committee on Cancer Staging Manual. 6th ed. (2002), Springer-Verlag, New York 223-240
6. Weiss C.M., Fowble L.B., Solin J.L., et al. Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys 23 (1992) 941-947
7. Thurman S.A., Schnitt S.J., Connolly J.L., et al. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. Int J Radiat Oncol Biol Phys 59 (2004) 152-159
8. Haffty G.B., Perrotta L.P., Ward B., et al. Conservatively treated breast cancer: outcome by histologic subtype. Breast J 3 (1997) 7-14
9. Diab S.G., Clark G.M., Osborne C.K., et al. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol 17 (1999) 1442-1448